Font Size: a A A
Keyword [Icotinib]
Result: 61 - 72 | Page: 4 of 4
61. Icotinib Combined With Shengmai Capsule In The Treatment Of Advanced Non-small Cell Lung Cancer
62. The Synergistic Inhibitory Effect Of Melittin Combined With Icotinib On Different Lung Adenocarcinoma Cell Lines And Reversal Of Drug Resistance
63. Clinical Efficacy And Influence Factors Of Icotinib Combined With Chemotherapy In The Treatment Of Advanced Lung Adenocarcinoma With EGFR Sensitive Mutations
64. Observation Of The Efficacy Of Icotinib Combined With Thoracic Radiotherapy In The Treatment Of Advanced NSCLC With EGFR Mutations
65. Clinical Observation Of Yinqiao Xiaozhan Prescription Combined With External Washing Of Four Yellow Water On Wind-heat Rash Caused By Icotinib
66. Studies Of Functional Role And Regulatory Mechanism Of LncRNA APCDD1L-AS1 Contributing To Icotinib Resistance In Lung Adenocarcinoma
67. The Mechanism Study On The Metastasis Of Icotinib-Resistant Non Small Cell Lung Cancer
68. Study Of Icotinib Combined With Chemotherapy And Icotinib Monotherapy In Patients With EGFR-sensitive Mutations NSCLC After Recurrence
69. Efficacy And Influencing Factors Of Double-dose Ectinib In Patients With Advanced Non-small Cell Lung Cancer Harboring EGFRexon 21-L858R Mutation
70. Selective COX-2 Inhibitor Combined With EGFR-tyrosine Kinase Inhibitor Study On The Growth And Apoptosis Of Non-small Cell Lung Cancer And Its Mechanisms
71. Analysis Of The Efficacy Of First-generation TKI Targeted Drugs In Patients With EGFR Mutations In Advanced Lung Adenocarcinoma
72. Clinical Efficacy Of Icotinib In Patients Of Advanced Non-Squamous Non-Small Cell Lung Cancer Failed With The Second-Line Chemotherapy Along With Unknown EGFR Mutation
  <<First  <Prev  Next>  Last>>  Jump to